Using Transcranial Direct Current Stimulation tDCS to Reduce Craving and Improve Control in Alcohol Use Disorder
Comparing Different Brain Stimulation Methods as Add-On Treatments During Detox
Led by Central Institute of Mental Health, Mannheim · Updated on 2025-06-04
162
Participants Needed
2
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating transcranial direct current stimulation tDCS as an add-on treatment to reduce cognitive deficits and substance craving in individuals with substance use disorders, focusing on alcohol use disorder. The study aims to identify the best electrode placement and current direction for tDCS to improve inhibitory control and reduce craving, which could lead to longer abstinence and less substance use after relapse. This is important as previous findings on tDCS effects in this area have been conflicting.
Participants receive one of several interventions alongside standard detoxification treatment three different active tDCS conditions targeting specific brain areas, a sham placebo tDCS, computerized inhibition training, or no additional intervention. tDCS sessions last 20 minutes each and are given on five consecutive days, with electrodes placed precisely using an EEG cap. Inhibition training uses a computerized GoNo-Go task with alcohol-related images.
Participants undergo psychometric, neuropsychological, and EEG assessments before, during, and after the interventions, including tasks measuring inhibitory control. Follow-up occurs at 4, 8, 12, and 24 weeks post-treatment to assess craving, relapse, and alcohol use. EEG and behavioral tests are repeated to monitor changes. The total study duration includes intervention days and several follow-up assessments to track long-term outcomes.
CONDITIONS
Brief Title
Modification of Inhibitory Control and Craving Through Transcranial Direct Current Stimulation (tDCS) as an Add-On Treatment for Substance Use Disorder
Research Team
S
Sabine Vollstädt-Klein, PhD
S
Sarah Gerhardt, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Main diagnosis of alcohol use disorder according to DSM-5
Patients of any gender aged 18 to 65
Normal vision or vision correctable with glasses or contact lenses
Able to communicate verbally and in writing
Able to give fully informed consent after reviewing study information
You will not qualify if you...
Withdrawal of consent
Severe internal, neurological, or psychiatric conditions (e.g., lifetime schizophrenia, bipolar disorder, severe depression, PTSD within the last 12 months)
Metal implants in the head or epilepsy preventing EEG/tDCS
Severe withdrawal symptoms (CIWA-R score greater than 7)
Use of psychoactive drugs within last 14 days (except certain withdrawal treatments stopped at least 3 days prior, or stable antidepressants/anxiolytics)
Drug or alcohol use within the last 7 days
Pregnancy in women
Suicidal tendencies or risk to others
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - 5 consecutive days
Participants receive their assigned intervention, which may include transcranial direct current stimulation (tDCS), computerized inhibition training, sham stimulation, or no intervention. Interventions occur on five consecutive days along with neuropsychological testing and EEG recordings on the first and last intervention days to assess inhibitory control and craving.
5 daily in-person visits, including baseline and final EEG assessments
Follow-up
Duration - 24 weeks
Participants are followed up to assess self-reported relapse, substance use, craving, and inhibitory control through telephone interviews and an in-person visit with EEG assessment at 12 weeks.
3 telephone follow-up calls at 4, 8, and 24 weeks; 1 in-person follow-up visit at 12 weeks
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
6
Similar Trials
Testing Combined Neurofeedback and TMS Treatments for Alcohol Use Disorder in Adults Aged 19 to 65
Study of CMND-100 Safety, Dosing, and Effects in Healthy Adults and Adults With Alcohol Use Disorder
Evaluating a New Blood Test to Help Diagnose and Monitor Depression and Psychosis in Adults
Evaluating Peer Recovery Coaching for Adults Hospitalized with Alcohol Use Disorder to Support Long-Term Recovery and Reduce Heavy Drinking
Study of Brain Stimulation to Enhance Motivational Interviewing for Adults Who Drink Alcohol at Risky Levels
Study Comparing Digital Avatar-Assisted CBT and Standard Face-to-Face CBT
for Treating Addiction and Intimate Partner Violence in Men Aged 18 to 65
Adaptive Web-Based Treatments for Alcohol Use in Military Spouses and Service Members Evaluating Partners Connect and CRAFT Interventions
Phase 3 Study Comparing Brenipatide With Placebo for Adults With Alcohol Use Disorder to Evaluate Efficacy and Safety
Phase 3 Study of Brenipatide Versus Placebo for Adults With Moderate-to-Severe Alcohol Use Disorder Assessing Efficacy and Safety
Evaluating Approach Avoidance Training to Improve Recovery in Veterans With Alcohol Use Disorder
A Study of Clinical and Brain Effects of Adjunctive Computer-Based Therapy
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Alcohol-specific inhibition training in patients with alcohol use disorder: a multi-centre, double-blind randomized clinical trial examining drinking outcome and working mechanisms.
Maria Stein, Leila M Soravia, Raphaela M Tschuemperlin...
Modification of inhibitory control and craving through transcranial direct current stimulation as an add-on treatment for substance use disorder: protocol for a randomized controlled study.